Arany E, Strain A J, Hube M J, Phillips I D, Hill D J
MRC Group in Fetal and Neonatal Health and Development, Lawson Research Institute, St. Joseph's Health Centre, London, England.
J Cell Physiol. 1993 May;155(2):426-35. doi: 10.1002/jcp.1041550225.
Isolated adult rat hepatocytes were used to investigate and compare the actions of glucose or amino acids and insulin, glucagon, growth hormone, and dexamethasone on the expression of insulin-like growth factor binding protein (IGFBP) mRNA, or the release of IGFBP and IGF peptides in vitro. Ligand blot analysis of culture medium conditioned for 24 h by monolayers of hepatocytes in the presence of 6.5 mM glucose revealed two species of IGFBPs, an abundant form of 30-32 kDa and a minor species of 22-24 kDa. Western blotting showed that two IGFBPs of 29-30 and 32 kDa were recognized by antiserum against hIGFBP-1, whereas hepatocytes contained a 1.6 kb transcript on Northern blot with a rat IGFBP-1 cDNA. Insulin-like growth factor BP-2 mRNA was not detected in hepatocytes and IGFBP-2 immunoreactive peptide not present in conditioned medium. The release of IGFBP-1, determined by ligand blot, was independent of glucose concentration over the range of 2.7 mM-11.1 mM, but IGFBP-1 mRNA was decreased following incubation with 6.5 mM glucose compared with 2.7 mM glucose. The release of IGFBP-1 by hepatocytes was inhibited by insulin (10 nM-1 microM), as was mRNA abundance. However, these effects of insulin on IGFBP-1 diminished with increasing glucose concentration. Increasing concentrations of total amino acids increased IGFBP-1 release as did dexamethasone (100 pM-100 nM), whereas growth hormone and glucagon were without effect. The release of IGF I was increased by insulin, growth hormone and dexamethasone but was decreased by glucagon and amino acids, whereas changes in glucose concentration had no effect. The results show that isolated adult rat hepatocytes release IGF I and IGFBP-1 under the interactive control of nutrients and hormones involved in metabolic homeostasis.
分离的成年大鼠肝细胞用于体外研究和比较葡萄糖或氨基酸以及胰岛素、胰高血糖素、生长激素和地塞米松对胰岛素样生长因子结合蛋白(IGFBP)mRNA表达或IGFBP和IGF肽释放的作用。在6.5 mM葡萄糖存在下,单层肝细胞培养24小时的条件培养基的配体印迹分析显示有两种IGFBP,一种丰富的30 - 32 kDa形式和一种较少的22 - 24 kDa形式。蛋白质免疫印迹表明,抗hIGFBP - 1抗血清识别出两种29 - 30 kDa和32 kDa的IGFBP,而肝细胞在Northern印迹上含有与大鼠IGFBP - 1 cDNA对应的1.6 kb转录本。在肝细胞中未检测到胰岛素样生长因子BP - 2 mRNA,条件培养基中也不存在IGFBP - 2免疫反应性肽。通过配体印迹测定,IGFBP - 1的释放在2.7 mM - 11.1 mM葡萄糖范围内与葡萄糖浓度无关,但与2.7 mM葡萄糖相比,在6.5 mM葡萄糖孵育后IGFBP - 1 mRNA减少。胰岛素(10 nM - 1 microM)抑制肝细胞释放IGFBP - 1,mRNA丰度也受到抑制。然而,胰岛素对IGFBP - 1的这些作用随着葡萄糖浓度的增加而减弱。总氨基酸浓度增加会增加IGFBP - 1的释放,地塞米松(100 pM - 100 nM)也是如此,而生长激素和胰高血糖素则无作用。胰岛素、生长激素和地塞米松增加IGF I的释放,但胰高血糖素和氨基酸使其减少,而葡萄糖浓度的变化没有影响。结果表明,分离的成年大鼠肝细胞在参与代谢稳态的营养物质和激素的相互作用控制下释放IGF I和IGFBP - 1。